NCT05973422View on ClinicalTrials.gov

Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes

NANot yet recruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

September 30, 2024

Study Completion Date

September 30, 2024

Conditions
Type 1 Diabetes
Interventions
DEVICE

SIGI Insulin Management System

Continuous subcutaneous insulin infusion with Sigi, and wearing the Dexcom G7 sensor using the Dexcom App.

All Listed Sponsors
lead

Tandem Diabetes Care, Inc.

INDUSTRY

NCT05973422 - Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes | Biotech Hunter | Biotech Hunter